Difference between revisions of "Template:Major drug groups"
Jump to navigation
Jump to search
imported>Seppi333 (c) |
imported>NSH002 (tidy up, remove colours) |
||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Major drug groups |
| − | | title | + | | title = [[Pharmacology]]: [[Anatomical Therapeutic Chemical Classification System|major drug groups]] |
| − | | listclass = hlist | + | | listclass = hlist |
| − | | state | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | + | | group1 = [[Human gastrointestinal tract|Gastrointestinal tract]]/<br />[[metabolism]] ([[ATC code A|A]]) | |
| − | + | | list1 = | |
| − | | group1 = [[Human gastrointestinal tract|Gastrointestinal tract]]/<br/>[[metabolism]] ([[ATC code A|A]]) | ||
| − | | list1 | ||
* ''stomach acid'' | * ''stomach acid'' | ||
** [[Antacid]]s | ** [[Antacid]]s | ||
| Line 21: | Line 19: | ||
* [[Dietary mineral]]s | * [[Dietary mineral]]s | ||
| − | + | | group2 = [[Blood]] and blood<br /> forming organs ([[ATC code B|B]]) | |
| − | + | | list2 = | |
| − | | group2 = [[Blood]] and blood<br/> forming organs ([[ATC code B|B]]) | + | * [[Antithrombotic]]s |
| − | | list2 | ||
| − | * [[Antithrombotic]]s | ||
** [[Antiplatelet drug|Antiplatelets]] | ** [[Antiplatelet drug|Antiplatelets]] | ||
** [[Anticoagulant]]s | ** [[Anticoagulant]]s | ||
** [[Thrombolytic drug|Thrombolytics/fibrinolytics]] | ** [[Thrombolytic drug|Thrombolytics/fibrinolytics]] | ||
| − | * [[Antihemorrhagic]]s | + | * [[Antihemorrhagic]]s |
** [[Platelet]]s | ** [[Platelet]]s | ||
| − | ** [[ | + | ** [[Coagulation|Coagulants]] |
** [[Antifibrinolytic]]s | ** [[Antifibrinolytic]]s | ||
| − | + | | group3 = [[Circulatory system|Cardiovascular<br /> system]] ([[ATC code C|C]]) | |
| − | + | | list3 = | |
| − | | group3 = [[Circulatory system|Cardiovascular<br/> system]] ([[ATC code C|C]]) | ||
| − | | list3 | ||
* ''cardiac therapy/[[antianginal]]s'' | * ''cardiac therapy/[[antianginal]]s'' | ||
** [[Cardiac glycoside]]s | ** [[Cardiac glycoside]]s | ||
| Line 53: | Line 47: | ||
** [[Renin inhibitor]]s | ** [[Renin inhibitor]]s | ||
| − | * [[Hypolipidemic agent|Antihyperlipidemics]] | + | * [[Hypolipidemic agent|Antihyperlipidemics]] |
** [[Statin]]s | ** [[Statin]]s | ||
** [[Fibrate]]s | ** [[Fibrate]]s | ||
** [[Bile acid sequestrant]]s | ** [[Bile acid sequestrant]]s | ||
| − | + | | group4 = [[Human skin|Skin]] ([[ATC code D|D]]) | |
| − | + | | list4 = | |
| − | | group4 = [[Human skin|Skin]] ([[ATC code D|D]]) | ||
| − | | list4 | ||
* [[Emollient]]s | * [[Emollient]]s | ||
* [[Cicatrizant]]s | * [[Cicatrizant]]s | ||
| Line 68: | Line 60: | ||
* [[ATC code D09|Medicated dressings]] | * [[ATC code D09|Medicated dressings]] | ||
| − | + | | group5 = [[Genitourinary system|Genitourinary<br /> system]] ([[ATC code G|G]]) | |
| − | + | | list5 = | |
| − | | group5 = [[Genitourinary system|Genitourinary<br/> system]] ([[ATC code G|G]]) | ||
| − | | list5 | ||
* [[Hormonal contraception]] | * [[Hormonal contraception]] | ||
* [[Fertility medication|Fertility agents]] | * [[Fertility medication|Fertility agents]] | ||
| Line 77: | Line 67: | ||
* [[Sex steroid|Sex hormones]] | * [[Sex steroid|Sex hormones]] | ||
| − | | group6 = [[Endocrine system|Endocrine<br/> system]] ([[ATC code H|H]]) | + | | group6 = [[Endocrine system|Endocrine<br /> system]] ([[ATC code H|H]]) |
| − | | list6 | + | | list6 = |
* [[Hypothalamic-pituitary hormone]]s | * [[Hypothalamic-pituitary hormone]]s | ||
* [[Corticosteroid]]s | * [[Corticosteroid]]s | ||
| Line 86: | Line 76: | ||
* [[Thyroid hormone]]s/[[Antithyroid agent]]s | * [[Thyroid hormone]]s/[[Antithyroid agent]]s | ||
| − | + | | group7 = [[Infection]]s and<br /> [[Wikt:infestation|infestations]] ([[ATC code J|J]], [[ATC code P|P]], [[ATCvet code QI|QI]]) | |
| − | + | | list7 = | |
| − | | group7 = [[Infection]]s and<br/> [[Wikt:infestation|infestations]] ([[ATC code J|J]], [[ATC code P|P]], [[ATCvet code QI|QI]]) | ||
| − | | list7 | ||
* [[Antimicrobial]]s: [[Antibacterial]]s ([[Antimycobacterial]]s) | * [[Antimicrobial]]s: [[Antibacterial]]s ([[Antimycobacterial]]s) | ||
* [[Antifungal drug|Antifungals]] | * [[Antifungal drug|Antifungals]] | ||
| Line 100: | Line 88: | ||
* [[Vaccine]]s | * [[Vaccine]]s | ||
| − | + | | group8 = [[Malignant]] disease<br /> ([[ATC code L|L01-L02]]) | |
| − | + | | list8 = | |
| − | | group8 = [[Malignant]] disease<br/> ([[ATC code L|L01-L02]]) | ||
| − | | list8 | ||
* [[Chemotherapy|Anticancer agents]] | * [[Chemotherapy|Anticancer agents]] | ||
** [[Antimetabolite]]s | ** [[Antimetabolite]]s | ||
| Line 111: | Line 97: | ||
** [[Topoisomerase inhibitor]]s | ** [[Topoisomerase inhibitor]]s | ||
| − | + | | group9 = [[Immune system|Immune]] disease<br /> ([[ATC code L|L03-L04]]) | |
| − | + | | list9 = | |
| − | | group9 = [[Immune system|Immune]] disease<br/> ([[ATC code L|L03-L04]]) | + | * [[Immunomodulator]]s |
| − | | list9 | ||
| − | * [[Immunomodulator]]s | ||
** [[Immunostimulant]]s | ** [[Immunostimulant]]s | ||
** [[Immunosuppressive drug|Immunosuppressants]] | ** [[Immunosuppressive drug|Immunosuppressants]] | ||
| − | + | | group10 = [[Muscle]]s, [[bone]]s,<br /> and [[joint]]s ([[ATC code M|M]]) | |
| − | + | | list10 = | |
| − | | group10 = [[Muscle]]s, [[bone]]s,<br/> and [[joint]]s ([[ATC code M|M]]) | ||
| − | | list10 | ||
* [[Anabolic steroid]]s | * [[Anabolic steroid]]s | ||
* [[Anti-inflammatory|Anti-inflammatories]] | * [[Anti-inflammatory|Anti-inflammatories]] | ||
| Line 131: | Line 113: | ||
* [[Bisphosphonate]]s | * [[Bisphosphonate]]s | ||
| − | + | | group11 = [[Human brain|Brain]] and<br /> [[nervous system]] ([[ATC code N|N]]) | |
| − | + | | list11 = | |
| − | | group11 = [[Human brain|Brain]] and<br/> [[nervous system]] ([[ATC code N|N]]) | ||
| − | | list11 | ||
* [[Analgesic]]s | * [[Analgesic]]s | ||
* [[Anesthetic]]s | * [[Anesthetic]]s | ||
| Line 167: | Line 147: | ||
* [[Wakefulness-promoting agent|Wakefulness-Promoting Agent]]s | * [[Wakefulness-promoting agent|Wakefulness-Promoting Agent]]s | ||
| − | + | | group12 = [[Respiratory system|Respiratory<br /> system]] ([[ATC code R|R]]) | |
| − | + | | list12 = | |
| − | | group12 = [[Respiratory system|Respiratory<br/> system]] ([[ATC code R|R]]) | ||
| − | | list12 | ||
* [[Decongestant]]s | * [[Decongestant]]s | ||
* [[Bronchodilator]]s | * [[Bronchodilator]]s | ||
| Line 176: | Line 154: | ||
* [[H1 antagonist|H<sub>1</sub> antagonist]]s | * [[H1 antagonist|H<sub>1</sub> antagonist]]s | ||
| − | + | | group13 = [[Sense|Sensory organ]]s ([[ATC code S|S]]) | |
| − | + | | list13 = | |
| − | | group13 = [[Sense|Sensory organ]]s ([[ATC code S|S]]) | ||
| − | | list13 | ||
* [[Ophthalmology|Ophthalmologicals]] | * [[Ophthalmology|Ophthalmologicals]] | ||
* [[Otology|Otologicals]] | * [[Otology|Otologicals]] | ||
| − | | group14 = Other ATC ([[ATC code V|V]]) | + | | group14 = Other ATC ([[ATC code V|V]]) |
| − | | list14 | + | | list14 = |
* [[Antidote]]s | * [[Antidote]]s | ||
* [[Contrast medium|Contrast media]] | * [[Contrast medium|Contrast media]] | ||
* [[Radiopharmacology|Radiopharmaceuticals]] | * [[Radiopharmacology|Radiopharmaceuticals]] | ||
* [[Dressing (medical)|Dressings]] | * [[Dressing (medical)|Dressings]] | ||
| + | |||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | |||
[[Category:Drug templates]] | [[Category:Drug templates]] | ||
| − | |||
</noinclude> | </noinclude> | ||
Revision as of 19:58, 2 April 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Major drug groups|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Major drug groups|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Major drug groups|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.